Funding
← Back to your selection

Merck Global Health Innovation Fund

Activity from announced rounds

Activity in this selectionOct 16, 2026 · Jul 19, 2026
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$107M
2 disclosed · full round size, not this investor’s share

By stage

Series A1
Series B1

By primary sector

Biotech1
Healthtech1

By country

United States2

Rounds

2 in this selection
N-Power Medicine

N-Power Medicine combines a community-oncology care network with clinical-trial data services for cancer drug developers.

$32MSeries B
Participant
Infinimmune

Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease

$75MSeries A
Role not disclosed